IRIS
MEROLA, BARTOLOMEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.956
NA - Nord America 1.728
EU - Europa 1.687
SA - Sud America 344
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 5.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.664
SG - Singapore 1.123
RU - Federazione Russa 923
CN - Cina 413
BR - Brasile 287
HK - Hong Kong 177
IT - Italia 148
DE - Germania 147
VN - Vietnam 130
FI - Finlandia 92
NL - Olanda 81
GB - Regno Unito 66
IE - Irlanda 62
SE - Svezia 58
UA - Ucraina 37
CA - Canada 32
MX - Messico 25
AR - Argentina 22
IN - India 22
ZA - Sudafrica 22
ES - Italia 17
PL - Polonia 15
TR - Turchia 14
JP - Giappone 13
BD - Bangladesh 12
CZ - Repubblica Ceca 10
EC - Ecuador 9
FR - Francia 9
IQ - Iraq 9
CI - Costa d'Avorio 7
ID - Indonesia 7
CL - Cile 6
CO - Colombia 6
PK - Pakistan 6
UZ - Uzbekistan 6
EE - Estonia 5
AT - Austria 4
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CM - Camerun 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
YE - Yemen 2
AD - Andorra 1
AQ - Antartide 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
NE - Niger 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
TG - Togo 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.770
Salva come PNG Salva come JPEG
Città #
Singapore 497
Moscow 205
Hong Kong 177
Chandler 163
Beijing 145
Ashburn 128
Millbury 111
Santa Clara 110
Jacksonville 91
Amsterdam 73
Princeton 73
Nanjing 70
Los Angeles 58
Naples 53
Ho Chi Minh City 51
Wilmington 41
São Paulo 37
Munich 36
Norwalk 33
Redondo Beach 29
Buffalo 28
Nanchang 26
New York 26
Hanoi 23
Boston 21
Dallas 20
San Jose 19
Chicago 17
Houston 17
The Dalles 17
Warsaw 15
Poplar 14
Montreal 13
Tokyo 13
Orem 12
Denver 11
Johannesburg 11
Mexico City 11
Ottawa 11
Shenyang 11
Chennai 10
Helsinki 10
Kunming 10
Brno 9
Brooklyn 9
London 9
Rio de Janeiro 9
Tianjin 9
Curitiba 8
Hải Dương 8
Jiaxing 8
San Francisco 8
Turku 8
Ankara 7
Belo Horizonte 7
Brasília 7
Indiana 7
Manchester 7
Toronto 7
Atlanta 6
Guangzhou 6
Haiphong 6
Hebei 6
Madrid 6
Napoli 6
Querétaro 6
Rome 6
Tashkent 6
Ningbo 5
Phoenix 5
Quito 5
Ribeirão Preto 5
Seattle 5
Stockholm 5
Torino 5
Boydton 4
Changsha 4
Da Nang 4
Itaquaquecetuba 4
Jakarta 4
Lanzhou 4
Araras 3
Biên Hòa 3
Buenos Aires 3
Can Tho 3
Cape Town 3
Casoria 3
Charlotte 3
Dhaka 3
Erbil 3
Goiânia 3
Lahore 3
Lavras 3
Mendoza 3
Milan 3
Ninh Bình 3
Osasco 3
Paris 3
Riyadh 3
San Diego 3
Totale 2.844
Salva come PNG Salva come JPEG
Nome #
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 136
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 123
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 110
Acute administration of hexarelin stimulates GH secretion during day and night in normal men. 109
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 108
Changes of lung volumes and respiratory muscle strength in patients with growth hormone deficiency 107
Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain 105
Prediction of efficacy of octreotide therapy in patients with acromegaly 105
Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD) 104
Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas 103
Cardiac effects of GH 101
Failure of long-term therapy with sodium valproate in Cushing's disease. 98
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing's disease 98
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 98
Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas 97
CV 205-502 treatment in therapy-resistant acromegalic patients 96
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas 96
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males 95
Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration 95
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 93
Hormonal gradients between inferior petrosal sinuses in various pituitary diseases 92
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment 91
The use of intercavernous sinuses phlebography in the diagnosis of ACTH-secreting microadenomas 91
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 91
Acromegaly 89
Effect of growth hormone on cardiac function 89
Plasma prolactin levels in the inferior petrosal sinuses in various pituitary disorders during perihypophyseal phlebography 88
Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration 88
Comparison of anterior pituitary hormone levels between the inferior petrosal sinuses and peripheral blood in various pituitary disorders during perihypophyseal phlebography 88
Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood 87
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 87
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 86
Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. 85
Effect of different dopaminergic agents in the treatment of acromegaly 85
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas 84
Lung volumes and respiratory muscle strength in adult patients with childhood- or adult-onset growth hormone deficiency: effect of 12 months' growth hormone replacement therapy. 84
Corticotropin-releasing hormone test: improvement of the diagnostic accuracy of simultaneous and bilateral inferior petrosal sinus sampling in patients with Cushing syndrome 83
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. 83
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly 83
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. 82
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies. 80
Fixity of vocal cords and laryngocele in acromegaly 76
Bilateral and simultaneous inferior petrosal sinus sampling in the early diagnosis of an ACTH-producing pituitary microadenoma and its detection by magnetic resonance one year later 76
New medical approaches in pituitary adenomas. 75
Efficacia e tollerabilità dell' octreotide (sandostatin, Sandoz) nell' acromegalia: vaòutazione su 20 pazienti. 74
Hyperthyroidism due to a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma associated with functional hyperprolactinaemia. A case report. 72
Bone mineral density and circulating cytokines in patients with acromegaly 71
Height, weight, height velocity of primary school population sample in Campania region 71
Abnormal vascular reactivity in growth hormone deficiency. 70
The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency 70
Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies 69
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 68
Prostatic hyperplasia: an unknown feature of acromegaly 68
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease 67
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 63
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 62
Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD 60
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. 57
Changes in GH-releasing hormone (GHRH) and somatostatin (SRIF) levels in hypophyseal portal blood (HPB) of conscious sheep during acute emotional stress. 57
Effect of octreotide pretreatment on surgical outcome in acromegaly 56
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage 55
Langerhans cell histiocytosis, diabetes insipidus, hyperprolactinemia and empty sella: a four-fold association. Report of two cases 52
Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas 50
Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly 50
Rapid and long-lasting suppression on prolactin secretion and shrinkage of prolactinomas with improved tolerability after injection of long-acting repeatable form of bromocriptine (Parlodel LAR) 50
Impaired cardiac performance is a distinct feature of uncomplicated acromegaly 50
Effect of a short-term treatment with recombinant growth hormone (GH) on adrenal responsiveness to corticotrophin stimulation in children affected by isolated GH deficiency 49
Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases 49
Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly. 47
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia 47
Prolactin in the inferior petrosal sinuses 46
Randomized comparative study using carbocalcitonin i.m. vs carbocalcitonin nasal spray vs ipriflavone x os in the treatment of post-menopausal osteoporosis 45
Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. 37
Growth hormone and the heart 36
Totale 5.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 5 1 7 6 10 7
2021/2022452 0 0 0 0 10 59 7 11 68 44 73 180
2022/2023438 73 30 18 17 56 35 4 37 55 72 25 16
2023/2024258 17 52 44 22 7 8 6 6 0 5 41 50
2024/20251.933 84 118 5 11 31 110 214 118 113 207 757 165
2025/20262.127 405 197 338 372 639 149 27 0 0 0 0 0
Totale 5.838